This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

TherapeuticsMD To Hold Second Quarter 2014 Financial Results Conference Call And Webcast On August 6

TherapeuticsMD (NYSE MKT:TXMD), a women’s healthcare company, today announced that it will hold a conference call and live audio webcast to discuss its second quarter financial and business results Wednesday, August 6. The conference call and webcast will take place at 4:30 p.m. EDT and will be hosted by Robert Finizio, Chief Executive Officer, and Dan Cartwright, Chief Financial Officer.

Details for the call and webcast include:

Date   Wednesday, August 6, 2014
Time   4:30 p.m. EDT
Telephone access: U.S. and Canada   866-665-9531
Telephone access: International   724-987-6977
Access code for all callers   81301505
Live audio webcast

See Homepage or Investors section


Shortly after completion of the call and webcast, a webcast replay and an audio replay will be available for at least 30 days on the Company's website at under the Investors section.

About TherapeuticsMD, Inc.

TherapeuticsMD, Inc. is a women’s healthcare company focused on developing and commercializing products exclusively for women. TherapeuticsMD is developing advanced hormone therapy pharmaceutical products based on novel technologies that enable delivery of bio-identical hormones through a variety of dosage forms and administration routes. The company also manufactures and distributes branded and generic prescription prenatal vitamins, as well as over-the-counter vitamins and cosmetics, under the vitaMedMD ® and BocaGreenMD ® brands. More information is available at the following websites:,,, and

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!


DOW 18,070.40 +46.34 0.26%
S&P 500 2,114.49 +6.20 0.29%
NASDAQ 5,016.9290 +11.5380 0.23%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs